

Helping find the most difficult-to-reach patients
Finding and recruiting patients with rare conditions is often a major impediment for clinical trials. We combine patient-finding technology with our robust international team of PMLs to identify barriers to finding and enrolling patients in rare trials. Pinpoint drives extensive and successful recruitment campaigns to help improve patient enrollment in clinical trials.
.png)
Trial enrollment success depends on patient and provider awareness.
Successful trial enrollment starts at the trial site. Our team of expert PMLs can help increase patient access to targeted therapies through patient and provider awareness.
Clinical Trial
Solutions
Patient
Enrollment
Oncology
Awareness
Pathology
Education
Case Studies
Adam Caar
Developer
Use this space to introduce yourself and share your professional history.
Clinical Trial Awareness and Recruitment
Global Rare Biomarker Basket Trial
A pharmaceutical company developing precision therapies for cancer patients with targetable alterations was faced with the challenge of increasing awareness and driving enrollment in a basket trial for a single driver mutation program for a rare biomarker prevalent in <1% of the patient population.
Our Impact:
-
Created a comprehensive site engagement and cohort enrichment strategy
-
Provided trial education for Principle Investigators and other key site personnel, including trial information and screening recommendation materials created in multiple languages.
-
Developed a molecular screening strategy for trial sites and established systematic screening at all sites across 4 countries
-
Rare patients identified across multiple tumor types
-
Provided real-time data and progress updates to the pharmaceutical company.
Adam Caar
Developer
Use this space to introduce yourself and share your professional history.
Clinical Trial Recruitment
Non-Muscle Invasive Bladder Cancer
A biopharmaceutical company focused on developing and commercializing innovative therapies for people with debilitating diseases was faced with the following challenges:
-
Accelerated clinical trial enrollment of an investigational medicine for non-muscle invasive bladder cancer.
-
Provided potential participants a patient-friendly and direct way to learn about this clinical trial and sign up to participate.
-
Created a secure environment to share data with clinical trial staff to facilitate screening and enrollment into the clinical trial
Pathologist & Oncologist Education
NTRK & RET webinar Series
A webinar series designed to help pathologists learn best practices in testing for TRK, RET, MET, and other emerging mutations in a wide range of tumor histologies.




Pinpoint was built to solve specific rare patient target bottlenecks
_edited.png)
_edited.png)
_edited.png)
_edited.png)
We are not a PR firm, we understand clinical trials and specifically rare patient clinical trials.
In addition to our patient enrollment technology we have a large network of pathologists in 16 countries with a five-year history of working together on TRK, RET, ROS1 and other rare disease trials.
We are the only services company that works from the pathologist to the patient/caregiver to enroll more patients in your trials.
We balance large pharma compliance with the need for hustle in small biotechs
Why Work With Us?
Contact
Inquiries
For any inquiries, questions or commendations, please call: 303-531-1667 or fill out the following form
Pinpoint by Celerity Biosciences
300 Center Drive
Suite G-310
Superior, CO 80026
Tel: 303-531-1667